Supplementary material. Table S1. Comparison of guidelines and recommendations definitions of exacerbations of COPD. Table S2. Comparison of guidelines and recommendations assessment of exacerbation risk. (DOCX 30Â kb
Assessment of the included studies. Characteristics and risk of bias assessment of the included stud...
Independent variables in treatment selection weighting models for cost analyses. Description of inde...
Study design Figure. Abbreviations: BDI, Baseline Dyspnoea Index; CAT, COPD Assessment Test; FP/SAL,...
Table S1. Baseline characteristics by treatment group for patients included in this analysis and for...
AGREE II. A critical group appraisal of: Pulmonary rehabilitation for patients with chronic pulmonar...
Online supplement (DOC). Figure S1. Histograms showing propensity score distribution. Table S1. Base...
Additional file 1: Figure S1. Flowchart of patient selection. Table S1. Codes used for identificatio...
COPD-related medications. COPD-related treatments identified by pharmacy claims in the baseline peri...
Fig S1. Kaplan–Meier curves and Cox proportional hazard model on time to first moderate-to-severe CO...
Comparison of patients with AECOPD with and without ECAC (ECAC diagnosed by 75% area reduction thres...
The league table of the network for the estimation of clinical cure rates of the treatments accordin...
Forest plot of TDI focal score at Day 168, active treatments versus PBO. (DOCX 101 kb
Interactions between IgG subclass levels and inhaled steroid use at enrollment and use of systemic s...
List of institutions and Independent Ethics Committees/Institutional Review Boards for Study DB21161...
Table S1. Ten-Year CVD Risk by GOLD classification and selected baseline characteristics in COPD pat...
Assessment of the included studies. Characteristics and risk of bias assessment of the included stud...
Independent variables in treatment selection weighting models for cost analyses. Description of inde...
Study design Figure. Abbreviations: BDI, Baseline Dyspnoea Index; CAT, COPD Assessment Test; FP/SAL,...
Table S1. Baseline characteristics by treatment group for patients included in this analysis and for...
AGREE II. A critical group appraisal of: Pulmonary rehabilitation for patients with chronic pulmonar...
Online supplement (DOC). Figure S1. Histograms showing propensity score distribution. Table S1. Base...
Additional file 1: Figure S1. Flowchart of patient selection. Table S1. Codes used for identificatio...
COPD-related medications. COPD-related treatments identified by pharmacy claims in the baseline peri...
Fig S1. Kaplan–Meier curves and Cox proportional hazard model on time to first moderate-to-severe CO...
Comparison of patients with AECOPD with and without ECAC (ECAC diagnosed by 75% area reduction thres...
The league table of the network for the estimation of clinical cure rates of the treatments accordin...
Forest plot of TDI focal score at Day 168, active treatments versus PBO. (DOCX 101 kb
Interactions between IgG subclass levels and inhaled steroid use at enrollment and use of systemic s...
List of institutions and Independent Ethics Committees/Institutional Review Boards for Study DB21161...
Table S1. Ten-Year CVD Risk by GOLD classification and selected baseline characteristics in COPD pat...
Assessment of the included studies. Characteristics and risk of bias assessment of the included stud...
Independent variables in treatment selection weighting models for cost analyses. Description of inde...
Study design Figure. Abbreviations: BDI, Baseline Dyspnoea Index; CAT, COPD Assessment Test; FP/SAL,...
DOI
Add to ORKG